Cagrilintide + Semaglutide 5mg (10 Vials / Kit)

Cagrilintide / Semaglutide at a glance

Two separate molecules share this vial. Cagrilintide is a long-acting analogue of amylin, a hormone the pancreas releases together with insulin, modified with a fatty-acid chain to extend its activity. Semaglutide is a lipidated GLP-1 receptor agonist and the active substance in several approved prescription medicines. Novo Nordisk has developed the pair as a fixed combination known as CagriSema. The listing here is research material, not a clinical formulation, and it is not interchangeable with any medicine.

Price and availability

Sold by SSRBIO and sent from China, this listing is a kit of 10 vials at 5mg each (50 mg in total). $126.00 buys the whole kit, which is $2.52/mg. 4 brands sell Cagrilintide / Semaglutide on GLP1 Forum Escrow, with a typical price of $1.45–$1.70 per mg (median $1.70); this listing is above the typical range. As with every order here, the brand is paid only after you confirm delivery.

What it is studied for

Amylin and GLP-1 act on related but distinct appetite circuits. Cagrilintide engages amylin receptors, which form when the calcitonin receptor pairs with accessory proteins, and acts in the hindbrain to slow gastric emptying and signal fullness. Semaglutide binds GLP-1 receptors in the pancreas, gut and brain, where it is studied for glucose-dependent insulin release and appetite reduction. Because the two pathways overlap only in part, researchers examine whether combining them changes the response compared with either agent alone; the vial itself does not establish such an effect.

Research and regulatory status

Novo Nordisk has run large late-stage trials of the combination in obesity and type 2 diabetes, and results have been presented and published. The combined product does not yet hold full regulatory approval. Cagrilintide on its own remains investigational, while semaglutide is an approved drug substance in other products. Research material on this marketplace is not equivalent to any clinical product, and trial findings describe the sponsor's formulation, not these vials.

Checking the lab data

Because two peptides share the vial, the report should treat them separately. Mass spectrometry should identify cagrilintide and semaglutide at their expected masses, and HPLC should resolve the two peaks and quantify each one against the labeled amounts, rather than giving a single combined purity. Both are lipidated, so a mass that comes in too light can point to a missing side chain. The cake should be white and uniform, with a matching batch number.

This listing has no third-party report on file yet. The lab reports directory and the Cagrilintide / Semaglutide page show which brands do publish testing.

Listing details

Compound

Cagrilintide / Semaglutide

Synonyms

CagriSema, Cagri-Sema

Class

Amylin analogue + GLP-1 receptor agonist combination

Format

Lyophilized (freeze-dried) powder

Vial strength

5mg

Vials per kit

10

Total content

50 mg

Price per mg

$2.52

Sold by

SSRBIO

Ships from

China

Lab report

Not yet published

Storage and preparation

Freeze-dried peptide keeps best sealed, cold and dark. Once it has been dissolved, refrigerate it, avoid repeated warming and follow the stability limits in your study protocol.

Concentration arithmetic: one 5 mg vial dissolved in 2 mL gives 2.5 mg/mL, or 5 mg/mL in 1 mL. The Research Lab calculator in your dashboard handles any other volume.

Buyer questions

Supplied for laboratory research only. Not for human or veterinary use, and not a substitute for any prescription medicine. Nothing on this page is medical advice.